Related Experiment Videos
Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute
H Fidler1, A Dhillon, D Gertner
1Department of Liver Transplantation and Hepatobiliary Medicine, Royal Free Hospital, London, UK.
Abstract:
Fifteen reports of hepatitis induced by ecstasy (MDMA, 3,4-methylenedioxymetamphetamine) have been published over the last 3 years. With the increasing enthusiasm for "Rave" parties, the incidence appears to be increasing, and is an important and often concealed cause of acute hepatitis in young people. We report two cases of recurrent ecstasy-associated hepatitis where the interval between drug consumption and jaundice was variable and the link therefore initially obscured. Liver biopsies of both patients showed acute hepatitis. One was of relatively mild degree, and the other was severe, with features suggesting auto-immune hepatitis. Both cases resolved spontaneously. A high index of suspicion and careful specific enquiry are necessary to make the diagnosis and warn the patient to abstain in future, since subsequent attacks may be fatal and insidious chronic damage may occur.
Insights
Ecstasy (MDMA) can cause acute hepatitis, particularly in young people attending rave parties. Early diagnosis and abstinence are crucial, as recurrent exposure may lead to severe liver damage or fatal outcomes.
Area of Science:
- Hepatology
- Toxicology
- Public Health
Background:
- Ecstasy (3,4-methylenedioxymetamphetamine, MDMA) use is associated with increasing reports of drug-induced liver injury.
- Acute hepatitis is an important, often unrecognized, cause of liver damage in young adults.
- The rise in rave culture may contribute to a higher incidence of ecstasy-induced hepatitis.